Structure Info
- Chemspace ID
- CSCS20465146760 (Synthesis)
- IUPAC Name
- methyl (1S,14E,16R,19S)-14-ethylidene-6-hydroxy-2-methyl-18-oxa-2,12-diazahexacyclo[13.3.2.0¹,⁹.0³,⁸.0⁹,¹⁶.0¹²,¹⁹]icosa-3,5,7-triene-16-carboxylate
- Mol formula
- C22H26N2O4
- Mol weight
- 382 Da
- Catalog Number(s)
- HY-122189
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.55
- Heavy atoms count
- 28
- Rotatable bond count
- 2
- Number of rings
- 6
- Carbon bond saturation, Fsp3
- 0.59
- Polar surface area (Å)
- 62
- Hydrogen bond acceptors count
- 5
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSCS20465146760
Items Overall 4 items from 2 suppliers
Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
---|---|---|---|---|---|---|
MedChemExpress | 30 days | United States To: | 90 | 1 mg | 255 | |
MedChemExpress | 30 days | United States To: | 90 | 5 mg | 1,019 | |
Description: Names: Akuammine; (-)-Akuammine; Vincamajoridine; Product Description: Akuammine is an indole alkaloid that has been found in Picralima nitida and has analgesic activity. It selectively binds to the μ- and κ-opioid receptors over the δ-opioid receptor (Kis=0.3, 1.68, and 10.4 μM for the human receptors, respectively). Akuammine inhibits forskolin-induced cAMP production in HEK293 cells expressing human μ- or κ-opioid receptors ( IC 50 s=2.6 and 0.073 μM, respectively). It increases the latency to withdrawal in the tail-flick or hot plate test in mice when administered at a dose of 60 mg/kg.; CAS: 3512-87-6 | ||||||
MedChemExpress EU | 30 days | Sweden To: | 90 | 1 mg | 268 | |
MedChemExpress EU | 30 days | Sweden To: | 90 | 5 mg | 1,074 | |
Description: Names: Akuammine; (-)-Akuammine; Vincamajoridine; Product Description: Akuammine is an indole alkaloid that has been found in Picralima nitida and has analgesic activity. It selectively binds to the μ- and κ-opioid receptors over the δ-opioid receptor (Kis=0.3, 1.68, and 10.4 μM for the human receptors, respectively). Akuammine inhibits forskolin-induced cAMP production in HEK293 cells expressing human μ- or κ-opioid receptors (IC50s=2.6 and 0.073 μM, respectively). It increases the latency to withdrawal in the tail-flick or hot plate test in mice when administered at a dose of 60 mg/kg.; CAS: 3512-87-6 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire